The AUTAX (Austrian Multivessel TAXUS-Stent) Registry Another Useful Registry on Stented Angioplasty for Multivessel Disease?⁎⁎Editorials published in JACC: Cardiovascular Interventions reflect the views of the authors and do not necessarily represent the views of JACC: Cardiovascular Interventions or the American College of Cardiology. by Wijns, William
ET
(
T
A
A
W
A
A
(
W
r
A
4
A
o
t
c
b
r
a
i
c
f
t
p
t
d
Q
C
T
w
s
d
d
A
p
v
t
o
b
c
o
f
m
c
a
r
t
w
4
p
p
o
p
p
t
r
o
o
i
p
m
W
p
u
p
i
a
e
A
c
p
r
s
A
a
t
n
r
b
i
o
*
a
t
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 2 , N O . 8 , 2 0 0 9
© 2 0 0 9 B Y T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N I S S N 1 9 3 6 - 8 7 9 8 / 0 9 / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . D O I : 1 0 . 1 0 1 6 / j . j c i n . 2 0 0 9 . 0 6 . 0 0 8DITORIAL COMMENT
he AUTAX
Austrian Multivessel
AXUS-Stent) Registry
nother Useful Registry on Stented
ngioplasty for Multivessel Disease?*
illiam Wijns, MD, PHD
alst, Belgium
t the exact time when the 2-year results of the SYNTAX
Synergy Between Percutaneous Coronary Intervention
ith TAXUS and Cardiac Surgery) trial (1) are about to be
eported, one wonders what can be learned from the
UTAX (Austrian Multivessel TAXUS-Stent) registry, a
41-patient prospective, multicenter registry performed in
ustria in the years 2004 to 2005 and reported in this issue
f JACC: Cardiovascular Interventions (2).
See page 718
What did the authors consider as the key messages of
heir study? In the abstract, they state: “With the aim of
omplete revascularization, Taxus stent implantations can
e safe for patients with multivessel disease. The AUTAX
egistry, including patients with post-PCI lesions, provides
dditional information to the SYNTAX study.”
Thus, key features of the AUTAX registry are the
nclusion of real-life patients, the aim for complete revas-
ularization, and the use of Taxus stents. Findings pertain to
avorable safety metrics (low mortality, myocardial infarc-
ion, and stent thrombosis rates at 2 years), and the strong
ositive impact of complete revascularization on outcome.
Since no comparator group is available, understanding
he relevance of these findings requires a comprehensive
escription of the study design and patient population.
uestions Related to Study Design,
onduct, and Analysis
he registry was designed to include “all incoming patients
ith possible complete revascularization with PCI.” Pre-
Editorials published in JACC: Cardiovascular Interventions reflect the views of the
uthors and do not necessarily represent the views of JACC: Cardiovascular Interven-d
ions or the American College of Cardiology.
From the Cardiovascular Center Aalst, Aalst, Belgium.umably this prerequisite for complete revascularization
isqualified a large number of patients with multivessel
isease presenting at the participating centers. Cardiology in
ustria is very well developed, and the total burden of
atients with multivessel disease presenting at the 9 high
olume centers participating in the registry must be higher
han 1,000 over 2 years. If not, each center would perform
n average no more than 30 multivessel coronary artery
ypass graft (CABG) and 35 multivessel percutaneous
oronary intervention (PCI) procedures per year, which
bviously cannot be the case.
Of 1,012 patients screened on these premises, the pre-
erred option was selected by a multidisciplinary team. “The
ultidisciplinary team, which also included noninvasive
ardiologists, ensured that the most balanced and appropri-
te advice was consistently offered regarding the choice of
evascularization strategy.” In a way, this scenario is similar
o the preferred option registries in the SYNTAX trial,
hereby CABG was the choice of the team over PCI in a
:1 ratio. Much like in the SYNTAX study, PCI was
referred in the presence of comorbidities while CABG was
referred with increasing complexity of the coronary anat-
my. Unlike was the case in the SYNTAX study, the
referred option ratio between CABG and PCI was sur-
risingly 1:1. Surprisingly because in the AUTAX registry
he more complex cases that were still included in the
andomized arms of the SYNTAX study (the upper tertile
f SYNTAX scores) were sent to surgery, perhaps because
f the prerequisite of high chance of complete revascular-
zation with PCI. As a result, the SYNTAX scores of the
atients reported here correspond to the lower and inter-
ediate complexity subsets from the SYNTAX study.
hich are all those patients then, in whom PCI was the
referred option? First, nearly one-third of the patients
ndergoing PCI had refused CABG. Second, 42% of
atients in the PCI group had undergone prior revascular-
zation procedures, mostly PCI in 39%, and presented with
t least 1 restenosis in 27% of cases. The latter group is
xcluded from most trials, perhaps inappropriately. The
UTAX registry shows, indeed, that they are many. While
ontemporary trial design aims at inclusion of “real-life”
atients, exclusion of patients with prior percutaneous
evascularization restricts the ability to generalize trial re-
ults, yet trial relevance. This is a significant lesson from the
UTAX registry.
The issues related to patient’s preference are complex. It
ppears that despite the involvement of a multidisciplinary
eam, despite the failure of prior PCI in a significant
umber of instances, many patients in Austria seem to
efuse to undergo surgery. One would like to understand
etter the process that led to this decision: which type of
nformation was provided to the patient, how were the
ptions discussed and with whom? Depending on cultural
iversity, there are many areas in the world where patients
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729refer not to be involved in the balancing act of medical
ecision. In my own experience, it is very unusual that
atients presented with a consensus recommendation on
ehalf of interventional and surgical colleagues will actually
ecline that proposition, even if it were CABG. Today,
atients and physicians are torn between the (too) many
ptions available to them. After decades of explosive tech-
ological innovation, we have reached a stage where nearly
very condition can be treated in more than one way, leaving
he choice between several different options for each strat-
gy. This places extra demands on the information and the
onsent processes that should be driven by high ethical
tandards.
omparison of Outcomes
utcome in the present study was good, but the authors
isely refrain from emphasizing comparisons of outcomes
etween the AUTAX registry and previously reported
egistries (3,4) or randomized trials on multivessel disease
evascularization. One could indeed argue about differences
n patient baseline characteristics (less severe than in the
YNTAX study), differences in end point definitions (myo-
ardial infarction, use of target lesion revascularization
nstead of target vessel revascularization), differences in
alculation of event rates (based on time to first event
nalysis rather than on hierarchical ranking), lack of central
djudication of critical end points such as myocardial
nfarction and stent thrombosis (there is no tabulation of
efinite, probable, and possible thrombosis events). How-
ver, in the absence of a comparator group, results can only
e accepted “as is” and the study scrutinized in an attempt
o identify predictors of good outcome. When successful,
his exercise will provide useful information, to be added to
he wealth of data that matter and should be considered,
hen trying to identify “what is best for this individual
atient?” (5). From this perspective, 2 key lessons of this
egistry require our attention.
ey Lessons From the AUTAX Registry
ood results with stented angioplasty using Taxus stents for
ultivessel disease patients including a large proportion of
ases with prior PCI were dependent on a number of
equirements: careful patient selection, exclusion of the
ore complex coronary anatomy, achievement of complete
evascularization, dual antiplatelet therapy up to 2 years,
epeat angiography in 78% of cases followed by additional or
epeat PCI as required.
The threshold for repeat angiography used to be very low
n the early days of angioplasty. Today, systematic angiog-
aphy is no longer common practice since the introduction
f stents, let alone drug-eluting stents. The question arises
hether such attitude should not be reintroduced in patients Sith multiple stent implantation or high-risk features.
ilent restenosis and disease progression can be pro-actively
etected and treated, perhaps preventing later events, po-
entially more severe than repeat PCI. Increased mortality
nd infarction rates, especially during hospital stay, were
ignificantly associated with failure to achieve complete
evascularization. The authors do not specify how stenosis
ignificance was evaluated, but it would seem that decisions
ere taken purely on the basis of angiographic stenosis
everity. These results are difficult to reconcile with the
esults of the FAME (Fractional flow reserve versus An-
iography for Multivessel Evaluation) trial (6), which sup-
ort the use of a combined anatomic and functional stan-
ard (using pressure-derived fractional flow reserve) as the
ppropriate decision maker for multivessel revascularization
y PCI. Indeed, the FAME study showed that revascular-
zation decisions based on angiographic guidance result in
tenting of nonhemodynamically significant stenoses in a
ignificant proportion of cases. Interestingly, the SYNTAX
core did not predict outcome in the AUTAX registry, and
he authors offer several explanations for this observation.
n addition to those, one could hypothesize that patient
utcome relates primarily to the reduction in SYNTAX
core after PCI, an objective angiographic marker of
ompleteness of revascularization, and that chances to
chieve a larger delta decrease with increasing pre-
rocedural complexity, reflected by higher pre-procedural
cores. Given the high rate of complete revascularization
n the AUTAX registry, pre-procedural SYNTAX score
ould be expected to lose its predictive power. This
ntriguing observation calls for a post-hoc analysis of the
riginal SYNTAX dataset in order to evaluate the pre-
ictive value of changes in SYNTAX score achieved by
he PCI procedure, as compared with the predictive
ower of the baseline score.
onclusions
he authors should be commended for the results of this
rospective registry, in particular for their ability to select
atient and lesion subsets that are well suited for multivessel
ngioplasty using Taxus. Unlike the case in the SYNTAX
tudy and most other trials, patients with prior PCI were
ot excluded from this registry. More than the actual
utcome results, the AUTAX registry usefully draws the
ttention to the importance of completeness of revascular-
zation and tight follow-up (including angiography as felt
esirable) in patients with multivessel disease of low-to-
oderate complexity. No conclusions can be drawn regard-
ng equivalence or superiority of the preferred approach
ersus bypass surgery. With all due respect for our excellent
ustrian colleagues, the level of evidence provided by the
UTAX registry is not beyond, but rather behind, the
YNTAX study.
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